Keyphrases
Ablation
12%
Active Fixation
11%
Acute Coronary Syndrome
11%
Adenosine Triphosphate
10%
Arrhythmia
19%
Artificial Intelligence
10%
Atrial Fibrillation
50%
Atrial Fibrillation Ablation
16%
Atrioventricular Block
10%
Cardiac Implantable Electronic Device
11%
Cardiac Pacing
12%
Cardiac Resynchronization Therapy
51%
Cardioverter-defibrillator Implantation
29%
Clinical Outcomes
26%
Conduction System Pacing
11%
Confidence Interval
23%
CRT-D
12%
Defibrillation Testing
16%
Defibrillator
15%
Dual-chamber
14%
European Heart Rhythm Association
14%
European Society of Cardiology
17%
Hazard Ratio
16%
Heart Failure
15%
Hospitalized Patients
11%
Implantable Cardioverter Defibrillator Registry
20%
Implantable Cardioverter-defibrillator Shock
16%
Implantable Defibrillator
92%
Inappropriate Shock
15%
Israeli
37%
Lead Extraction
15%
Lead-related Complications
11%
Left Atrial Appendage
14%
Left Atrium
10%
Left Ventricular Ejection Fraction
16%
Left Ventricular Lead
10%
Medical Surveillance
10%
Odds Ratio
14%
Pacemaker
33%
Pacing Lead
17%
Patients with Heart Failure
11%
Persistent Atrial Fibrillation
12%
Pulmonary Vein Isolation
10%
Shock
19%
Sinus Rhythm
16%
ST-elevation Myocardial Infarction (STEMI)
14%
Transcatheter Aortic Valve Implantation
14%
Ventricular Arrhythmia
35%
Ventricular Fibrillation
14%
Ventricular Tachycardia
13%
Medicine and Dentistry
Acute Coronary Syndrome
9%
Apoplexy
11%
Atrial Fibrillation
74%
Atrioventricular Block
9%
Cardiac Dysrhythmia
14%
Cardiac Resynchronization Therapy
63%
Cardiology
26%
Cardiovascular System
17%
Congestive Heart Failure
54%
Coronary Care Unit
10%
COVID-19
10%
Defibrillation
33%
Defibrillator
41%
Echocardiography
12%
Ejection Fraction
9%
Electrocardiogram
12%
Faintness
10%
Hazard Ratio
18%
Heart Atrium Pacing
11%
Heart Left Ventricle Ejection Fraction
16%
Heart Pacing
13%
Heart Rhythm
17%
Heart Ventricle Arrhythmia
23%
Hemodynamic
12%
Implant
10%
Implantable Automatic Defibrillator
100%
Infection
9%
Lead Extraction
21%
Left Atrium
9%
Mitral Insufficiency
13%
Mortality Rate
9%
Multivariate Analysis
9%
New York Heart Association Class
9%
Odds Ratio
15%
Pacemaker Implantation
12%
Percutaneous Aortic Valve Replacement
18%
Permanent Pacemaker
15%
Platelet
9%
Prevalence
13%
Primary Prevention
11%
Pulmonary Vein
9%
Randomized Controlled Trial
10%
Recurrent Disease
9%
Reoperation
10%
Sinus Rhythm
14%
Sudden Cardiac Death
10%
Sudden Death
9%
Supraventricular Tachycardia
9%
Ventricular Fibrillation
16%
Ventricular Tachycardia
30%
